VRDN
Viridian Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $10.0M of Viridian Therapeutics, Inc.
Director and 10% owner
Bought$9,999,990
$22.00Price
454,545Shares
+13%Stake
What VRDN did for a copier
- $1,000 copied at Tue, Oct 28 open, $22.88
- $1,425
- S&P 500, same days
- +0.1%
Measured over 30 trading days, to the Dec 10 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −12.5% against the S&P 500, and 5 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Oct 23. Filed Mon, Oct 27, 4:30 PM ET, after the close. Returns use the Oct 28 open and the Dec 10 close. Not investment advice.